The purpose of this research is to gain a better understanding of patients’ experiences with bronchiectasis and to identify which signs, symptoms, and related impacts on daily life are the most important and relevant to patients with bronchiectasis.

The information collected during this study will help develop and refine questionnaires that future patients will complete to assess their bronchiectasis symptoms in upcoming clinical trials and other research studies.

This research is being funded by a grant (U01FD006687-01) from the United States Food and Drug Administration (FDA) to Insmed Inc. and Pharmerit – an OPEN Health company (Pharmerit).